The Form 4 filing, a report of an insider's stock trades, was filed on November 12, 2026. The PVLA transactions took place on November 10–11, before the filing date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-11 |
| Buy/Sell | sell |
| Transaction Count | 12 |
| Shares Transacted | 12,300 |
| Price | $166.63 |
| Total Transaction Value | $2,049,514.37 |
| Insider | |
| Ticker Symbol | PVLA |
| Company | PALVELLA THERAPEUTICS, INC. |
| Insider Name | Martini Jeffrey S |
| Insider Title | Chief Scientific Officer |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported under transaction code S. The record lists 12 sale transactions, with possible payment-related circumstances discussed below.
What was the average price of the transaction?
The average sale price was $166.63 per share, rounded to the nearest cent. This average covers the 12 transactions.
How did this transaction affect the insider's holdings?
Jeffrey S. Martini sold 12,300 shares and reported zero shares remaining in the reported balance. The sales covered 100.00% of the shares in that balance before the sales. The available details do not establish his holdings across other accounts.
What's the total transaction value?
The total value was $2,049,514.37 for all 12 sales, rounded to the nearest cent.
Are there any special circumstances around this transaction?
Yes. The transaction information points to a Rule 10b5-1 trading plan, which sets trading instructions in advance. The details do not show which sales the plan covered or when it began.
The information also points to a possible link to tax payments or an exercise price—the cost of using a right to buy shares. No footnote text is available to confirm the purpose or explain how any payment worked. Code S identifies sales; the available details do not establish that shares were held back or handed over for payment. They also do not establish that taxes were the only purpose.
For research purposes only; not investment advice.